245 related articles for article (PubMed ID: 2037667)
1. In elderly persons live attenuated influenza A virus vaccines do not offer an advantage over inactivated virus vaccine in inducing serum or secretory antibodies or local immunologic memory.
Powers DC; Fries LF; Murphy BR; Thumar B; Clements ML
J Clin Microbiol; 1991 Mar; 29(3):498-505. PubMed ID: 2037667
[TBL] [Abstract][Full Text] [Related]
2. Systemic and local antibody responses in elderly subjects given live or inactivated influenza A virus vaccines.
Powers DC; Sears SD; Murphy BR; Thumar B; Clements ML
J Clin Microbiol; 1989 Dec; 27(12):2666-71. PubMed ID: 2592535
[TBL] [Abstract][Full Text] [Related]
3. Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine.
Clements ML; Murphy BR
J Clin Microbiol; 1986 Jan; 23(1):66-72. PubMed ID: 3700610
[TBL] [Abstract][Full Text] [Related]
4. Human immune responses to influenza virus vaccines administered by systemic or mucosal routes.
Moldoveanu Z; Clements ML; Prince SJ; Murphy BR; Mestecky J
Vaccine; 1995 Aug; 13(11):1006-12. PubMed ID: 8525683
[TBL] [Abstract][Full Text] [Related]
5. Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly.
Treanor JJ; Mattison HR; Dumyati G; Yinnon A; Erb S; O'Brien D; Dolin R; Betts RF
Ann Intern Med; 1992 Oct; 117(8):625-33. PubMed ID: 1530193
[TBL] [Abstract][Full Text] [Related]
6. In previously immunized elderly adults inactivated influenza A (H1N1) virus vaccines induce poor antibody responses that are not enhanced by liposome adjuvant.
Powers DC; Hanscome PJ; Pietrobon PJ
Vaccine; 1995 Oct; 13(14):1330-5. PubMed ID: 8585289
[TBL] [Abstract][Full Text] [Related]
7. Induction of mucosal antibodies by live attenuated and inactivated influenza virus vaccines in the chronically ill elderly.
Gorse GJ; Otto EE; Powers DC; Chambers GW; Eickhoff CS; Newman FK
J Infect Dis; 1996 Feb; 173(2):285-90. PubMed ID: 8568287
[TBL] [Abstract][Full Text] [Related]
8. Use of live cold-adapted influenza A H1N1 and H3N2 virus vaccines in seropositive adults.
Treanor JJ; Roth FK; Betts RF
J Clin Microbiol; 1990 Mar; 28(3):596-9. PubMed ID: 2182673
[TBL] [Abstract][Full Text] [Related]
9. Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults.
Keitel WA; Cate TR; Nino D; Huggins LL; Six HR; Quarles JM; Couch RB
J Infect Dis; 2001 Jan; 183(2):329-332. PubMed ID: 11110645
[TBL] [Abstract][Full Text] [Related]
10. Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?
Tamura S; Ainai A; Suzuki T; Kurata T; Hasegawa H
Jpn J Infect Dis; 2016; 69(3):165-79. PubMed ID: 27212584
[TBL] [Abstract][Full Text] [Related]
11. Local and systemic immune response in nursing-home elderly following intranasal or intramuscular immunization with inactivated influenza vaccine.
Muszkat M; Greenbaum E; Ben-Yehuda A; Oster M; Yeu'l E; Heimann S; Levy R; Friedman G; Zakay-Rones Z
Vaccine; 2003 Mar; 21(11-12):1180-6. PubMed ID: 12559796
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease.
Edwards KM; Dupont WD; Westrich MK; Plummer WD; Palmer PS; Wright PF
J Infect Dis; 1994 Jan; 169(1):68-76. PubMed ID: 8277200
[TBL] [Abstract][Full Text] [Related]
13. Comparison of long-term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine.
Johnson PR; Feldman S; Thompson JM; Mahoney JD; Wright PF
J Med Virol; 1985 Dec; 17(4):325-35. PubMed ID: 4078559
[TBL] [Abstract][Full Text] [Related]
14. Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis.
Beyer WE; Palache AM; de Jong JC; Osterhaus AD
Vaccine; 2002 Jan; 20(9-10):1340-53. PubMed ID: 11818152
[TBL] [Abstract][Full Text] [Related]
15. Secretory immunological response after intranasal inactivated influenza A virus vaccinations: evidence for immunoglobulin A memory.
Wright PF; Murphy BR; Kervina M; Lawrence EM; Phelan MA; Karzon DT
Infect Immun; 1983 Jun; 40(3):1092-5. PubMed ID: 6852914
[TBL] [Abstract][Full Text] [Related]
16. Safety of and serum antibody response to cold-recombinant influenza A and inactivated trivalent influenza virus vaccines in older adults with chronic diseases.
Gorse GJ; Belshe RB; Munn NJ
J Clin Microbiol; 1986 Sep; 24(3):336-42. PubMed ID: 3531226
[TBL] [Abstract][Full Text] [Related]
17. Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine.
Powers DC; Belshe RB
J Infect Dis; 1993 Mar; 167(3):584-92. PubMed ID: 8440930
[TBL] [Abstract][Full Text] [Related]
18. Reduced infectivity of cold-adapted influenza A H1N1 viruses in the elderly: correlation with serum and local antibodies.
Powers DC; Murphy BR; Fries LF; Adler WH; Clements ML
J Am Geriatr Soc; 1992 Feb; 40(2):163-7. PubMed ID: 1740601
[TBL] [Abstract][Full Text] [Related]
19. IgA polymerization contributes to efficient virus neutralization on human upper respiratory mucosa after intranasal inactivated influenza vaccine administration.
Terauchi Y; Sano K; Ainai A; Saito S; Taga Y; Ogawa-Goto K; Tamura SI; Odagiri T; Tashiro M; Fujieda M; Suzuki T; Hasegawa H
Hum Vaccin Immunother; 2018 Jun; 14(6):1351-1361. PubMed ID: 29425074
[TBL] [Abstract][Full Text] [Related]
20. The humoral response to live and inactivated influenza vaccines administered alone and in combination to young adults and elderly.
Stepanova L; Naykhin A; Kolmskog C; Jonson G; Barantceva I; Bichurina M; Kubar O; Linde A
J Clin Virol; 2002 Apr; 24(3):193-201. PubMed ID: 11856620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
